 | • レポートコード：MRC23Q36306 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の前立腺治療市場について調査・分析し、世界の前立腺治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（薬物治療、外科治療）、用途別セグメント分析（病院、クリニック）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Eli Lilly and Company、Pfizer、Merck、GlaxoSmithKline、Abbott、Astellas Pharmaなどが含まれています。 世界の前立腺治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、前立腺治療市場規模を推定する際に考慮しました。本レポートは、前立腺治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、前立腺治療に関するビジネス上の意思決定に役立てることを目的としています。 ・前立腺治療市場の概要 - 前立腺治療のタイプ別セグメント - 世界の前立腺治療市場規模：タイプ別分析（薬物治療、外科治療） - 前立腺治療の用途別セグメント - 世界の前立腺治療市場規模：用途別分析（病院、クリニック） - 世界の前立腺治療市場規模予測（2018年-2029年） ・前立腺治療市場の成長トレンド - 前立腺治療の地域別市場規模（2018年-2029年） - 前立腺治療市場ダイナミクス - 前立腺治療の業界動向 - 前立腺治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：薬物治療、外科治療 - 世界の前立腺治療のタイプ別市場規模（2018年-2023年） - 世界の前立腺治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、クリニック - 世界の前立腺治療の用途別市場規模（2018年-2023年） - 世界の前立腺治療の用途別市場規模（2024年-2029年） ・前立腺治療の地域別市場規模 - 北米の前立腺治療市場規模（2018年-2029年） - アメリカの前立腺治療市場規模（2018年-2029年） - ヨーロッパの前立腺治療市場規模（2018年-2029年） - アジア太平洋の前立腺治療市場規模（2018年-2029年） - 中国の前立腺治療市場規模（2018年-2029年） - 日本の前立腺治療市場規模（2018年-2029年） - 韓国の前立腺治療市場規模（2018年-2029年） - インドの前立腺治療市場規模（2018年-2029年） - オーストラリアの前立腺治療市場規模（2018年-2029年） - 中南米の前立腺治療市場規模（2018年-2029年） - 中東・アフリカの前立腺治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Eli Lilly and Company、Pfizer、Merck、GlaxoSmithKline、Abbott、Astellas Pharma ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Prostate Health market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Prostate Health is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Prostate Health is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Prostate Health in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Prostate Health include Eli Lilly and Company, Pfizer, Merck, GlaxoSmithKline, Abbott and Astellas Pharma, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prostate Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Health.
The Prostate Health market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prostate Health market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Health companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Eli Lilly and Company
Pfizer
Merck
GlaxoSmithKline
Abbott
Astellas Pharma
Segment by Type
Drug Treatment
Surgical Treatment
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Health companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Health Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Drug Treatment
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Prostate Health Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Health Market Perspective (2018-2029)
2.2 Prostate Health Growth Trends by Region
2.2.1 Global Prostate Health Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate Health Historic Market Size by Region (2018-2023)
2.2.3 Prostate Health Forecasted Market Size by Region (2024-2029)
2.3 Prostate Health Market Dynamics
2.3.1 Prostate Health Industry Trends
2.3.2 Prostate Health Market Drivers
2.3.3 Prostate Health Market Challenges
2.3.4 Prostate Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Health Players by Revenue
3.1.1 Global Top Prostate Health Players by Revenue (2018-2023)
3.1.2 Global Prostate Health Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Health Revenue
3.4 Global Prostate Health Market Concentration Ratio
3.4.1 Global Prostate Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Health Revenue in 2022
3.5 Prostate Health Key Players Head office and Area Served
3.6 Key Players Prostate Health Product Solution and Service
3.7 Date of Enter into Prostate Health Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Health Breakdown Data by Type
4.1 Global Prostate Health Historic Market Size by Type (2018-2023)
4.2 Global Prostate Health Forecasted Market Size by Type (2024-2029)
5 Prostate Health Breakdown Data by Application
5.1 Global Prostate Health Historic Market Size by Application (2018-2023)
5.2 Global Prostate Health Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prostate Health Market Size (2018-2029)
6.2 North America Prostate Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prostate Health Market Size by Country (2018-2023)
6.4 North America Prostate Health Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Health Market Size (2018-2029)
7.2 Europe Prostate Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prostate Health Market Size by Country (2018-2023)
7.4 Europe Prostate Health Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Health Market Size (2018-2029)
8.2 Asia-Pacific Prostate Health Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prostate Health Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate Health Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Health Market Size (2018-2029)
9.2 Latin America Prostate Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prostate Health Market Size by Country (2018-2023)
9.4 Latin America Prostate Health Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Health Market Size (2018-2029)
10.2 Middle East & Africa Prostate Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prostate Health Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate Health Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Prostate Health Introduction
11.1.4 Eli Lilly and Company Revenue in Prostate Health Business (2018-2023)
11.1.5 Eli Lilly and Company Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Prostate Health Introduction
11.2.4 Pfizer Revenue in Prostate Health Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Prostate Health Introduction
11.3.4 Merck Revenue in Prostate Health Business (2018-2023)
11.3.5 Merck Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Prostate Health Introduction
11.4.4 GlaxoSmithKline Revenue in Prostate Health Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Prostate Health Introduction
11.5.4 Abbott Revenue in Prostate Health Business (2018-2023)
11.5.5 Abbott Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Detail
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Prostate Health Introduction
11.6.4 Astellas Pharma Revenue in Prostate Health Business (2018-2023)
11.6.5 Astellas Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details